纵横研报
Ticker Detail

600285.SHG

¥22.92+0.97% 羚锐制药 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Henan Lingrui Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.

MARKET 市值 12.85B CNY PE 16.3x Fwd 25.2x 52W ¥19 – ¥23.51 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY 10.3% ROE 22.6% 营业利润率 23.7% 净利润率 19.9%
ANALYST 股息率 5.06%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制